Common genetic variation drives molecular heterogeneity in human iPSCs
Nature2017Vol. 546(7658), pp. 370–375
Citations Over TimeTop 1% of 2017 papers
Helena Kilpinen, Ângela Gonçalves, Andreas Leha, Vackar Afzal, Kaur Alasoo, Sofie Ashford, Sendu Bala, Dalila Bensaddek, Francesco Paolo Casale, Oliver J. Culley, Petr Danecek, Adam Faulconbridge, Peter W. Harrison, Annie Kathuria, Davis J. McCarthy, Shane McCarthy, Ruta Meleckyte, Yasin Memari, Nathalie Moens, Filipa Soares, Alice Mann, Ian Streeter, Chukwuma A. Agu, Alex Alderton, Andrew Nelson, Sarah Harper, Minal Patel, Alistair White, Sharad Patel, Laura Clarke, Reena Halai, Christopher M. Kirton, Anja Kolb‐Kokocinski, Philip L. Beales, Ewan Birney, Davide Danovi, Angus I. Lamond, Willem H. Ouwehand, Ludovic Vallier, Fiona M. Watt, Richard Durbin, Oliver Stegle, Daniel J. Gaffney
Related Papers
- → Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy(2020)68 cited
- → The reprogramming therapy for a patient with advanced hepatocellular carcinoma by using human-induced pluripotent stem (iPS) cells technology(2013)3 cited
- The research advances on human induced pluripotent stem cells in vitro to produce red blood cells(2015)
- Abstract 20894: Therapeutic Efficacy of the Exosomes Derived From Human Induced Pluripotent Stem Cells (iPSCs) vs. Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes (iCMs) in Murine Myocardial Injury Model(2017)
- → Modeling Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells(2016)